Article thumbnail

An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors

By Eric J. Lepin, Jeffrey V. Leyton, Yu Zhou, Tove Olafsen, Felix B. Salazar, Katelyn E. McCabe, Scott Hahm, James D. Marks, Robert E. Reiter and Anna M. Wu
Topics: Original Article
Publisher: Springer-Verlag
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2003). AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging
  2. Antibodies and antimatter: the resurgence of immuno-PET.
  3. (1991). Applications of high efficiency lithium acetate transformation of intact yeast cells using single-stranded nucleic acids as carrier.
  4. Capromab Pendetide imaging of prostate cancer.
  5. (1999). Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer.
  6. (2004). Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37 degrees C. Protein Eng Des Sel
  7. Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity.
  8. Discovery of new markers of cancer throughserial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.
  9. (1999). Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. Cancer Res
  10. (2010). GagnonMK,HausnerSH,MarikJ,AbbeyCK,MarshallJF,Sutcliffe JL.High-throughput in vivoscreening oftargetedmolecularimaging agents.
  11. (2001). High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res
  12. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment.
  13. (2008). Humanized radioiodinated minibody for imaging of prostate stem cell antigen-expressing tumors. Clin Cancer Res
  14. (1995). Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in a nude mouse xenograft carcinoma model. Cancer Res
  15. Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptorexpressing tumor cells.
  16. (1992). MillerLS,etal.Therapeuticadvantageofhigh-affinityanticarcinoma radioimmunoconjugates. Cancer Res
  17. Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A.
  18. Molecular imaging of prostate cancer.
  19. New agents and techniques for imaging prostate cancer.
  20. NielsenUB,AdamsGP,WeinerLM,MarksJD.Targetingofbivalent anti-ErbB2diabodyantibodyfragmentstotumorcellsisindependent of the intrinsic antibody affinity.
  21. (2003). Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases. Appl Immunohistochem Mol Morphol
  22. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.
  23. (2001). Prostate stem cell antigen is overexpressed in human transitional cell carcinoma. Cancer Res
  24. (2005). Prostate stem cell antigen is overexpressed in prostate cancer metastases. Clin Cancer Res
  25. (1998). Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.
  26. Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies. Cancer Res 1988;48:4597–603.
  27. RaffAB,GrayA,KastWM.Prostatestemcellantigen:aprospective therapeutic and diagnostic target.
  28. Substantial energetic improvement with minimal structural perturbation in a high affinity mutant antibody.
  29. (2005). Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments. Cancer Res
  30. Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody.
  31. Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44V6 in nude mice bearing head-and-neck cancer xenografts.
  32. (2006). Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragment. Nat Protoc